Ascophyllum nodosum, ext.
CAS 84775-78-0
Ascophyllum nodosum, ext. (CAS 84775-78-0) is a pharmaceutical compound with 0 bioactivity targets and 1 adverse event association.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
Ascophyllum nodosum, ext. is linked to DTXSID00109168 in DSSTox identifiers.
View industrial chemical data →Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Ascophyllum nodosum, ext. used for in pharmaceutical contexts?
Ascophyllum nodosum, ext. (CAS 84775-78-0) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Ascophyllum nodosum, ext.?
Ascophyllum nodosum, ext. has 1 DrugCentral/FAERS adverse event association. Rendered reaction terms include Surgery. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Ascophyllum nodosum, ext. also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Ascophyllum Nodosum Extract with EU status "permitted".
What clinical phase is Ascophyllum nodosum, ext. in?
No phase 1-4 clinical development badge is rendered for Ascophyllum nodosum, ext. because the matched compound identifier rows do not contain a max-phase value.